More Cowbell! To end ALS, Riders of the Tri-State Trek Cycle 270 Miles - Making Noise and Rais...( CAMBRIDGE Mass. April 29 -- Hund...),Health

CAMBRIDGE, Mass., April 29 /PRNewswire-USNewswire/ -- Hundreds of bicyclists are expected to participate in the sixth annual Tri-State Trek, a three-day fundraising ride starting in Newton, Massachusetts and finishing in White Plains, New York, this July 18-20. The event and its participants raise money and awareness for the fatal neuromuscular disorder amyotrophic lateral sclerosis (ALS), Lou Gehrig's disease. Looking to be 300 strong this summer, the Trek is distributing cowbells in the communities it passes through so that spectators can help to cheer on the group of riders, which includes the armature and experienced rider as well as ALS patients.

"This bike ride is about raising money and bringing attention to the work we're doing to find a cure for a horrific disease," says Sean Scott, President of the ALS Therapy Development Institute (ALS TDI), a nonprofit biotechnology company in Cambridge, Mass. and the beneficiary of this three-day fundraiser. "The people who participate in the Trek do it to support the research we do here. They ride because they want to see changes in medical science, and the spectators who cheer them on and ring those cowbells let them know they're not alone on their bikes."

The world's largest ALS research facility, ALS TDI, employs a team of 30 of the best and brightest research scientists and technicians. They work together at the institute's state-of-the-art laboratory in Cambridge. Driven by a single, profoundly important goal -- to discover viable treatments for ALS as quickly as they possibly can -- the group is focused exclusively on curing ALS.

"We're so proud to ride for such a wonderful organization," says Mat Mendel, the event's founder, organizer and long time cyclist. "I know cowbells and bicycles won't cure this disease, but I believe the work being done at TDI will. The more people that ride and the more noise we make, the more attention we will bring to the brave patients who fight this
'/>"/>